ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

OPTI Optibiotix Health Plc

18.25
0.25 (1.39%)
Last Updated: 08:09:48
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 1.39% 18.25 18.00 18.50 18.25 18.00 18.00 67,816 08:09:48
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 6.43 16.64M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 18p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £16.64 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.43.

Optibiotix Health Share Discussion Threads

Showing 42901 to 42923 of 147575 messages
Chat Pages: Latest  1727  1726  1725  1724  1723  1722  1721  1720  1719  1718  1717  1716  Older
DateSubjectAuthorDiscuss
28/8/2018
07:51
Rayracs losses and the continued share price growth of Opti are sending him over the edge.......For the good of Rayracs mental stability please ignore his rather silly posts.
greenas1953
28/8/2018
00:03
Is it jet-lag or has the BB descended into farcical posts. I note elrico no longer posts here, yet his attention is still required by the children. I think i'll go catch up on some much needed sleep. I'm not missing anything here.
incanus
27/8/2018
23:41
You forget, the nhs would fund it. So why don’t they want to fund opti’s wonder product?! Because it wouldn’t do the job! That’s probably why you have bother getting cash hitting the bottom line from contracts!

Why wouldn’t the NHS look at LP-LDL? If they did, then there’s a good chance it worked. It’s obvious!! It’s not working or they’d use it to save £millions. They would rather use a pill costing them £millions?

Come on, it’s obvious!

rayrac
27/8/2018
23:16
Hey Raywhack, keep up



elrico
00:08 (23 hours ago)
'Holy Grail' diet pill could help millions lose weight in middle age.

A snip at c£220 per month.

slartybartfaster
27/8/2018
22:57
ray best way to lose pounds buy bpc lol 1000s of them
manc10
27/8/2018
22:53
gastrick band fitted price 4000 plus vat no mention of slimbiome lol
manc10
27/8/2018
22:52
BTW US only..how much a week. Bloody hell, you wouldnt able to feed the rest of the family while dieting. lol
slartybartfaster
27/8/2018
22:52
EME? You are joking!?
rayrac
27/8/2018
22:51
Are thick or blind Raywhack, manc has already said elrico posted the it over the weekend you fool. Unlike you, he isn't afraid of posting such info. If your honest you probably found on elrico forum. You much have slipped through the net.

Did you see his latest work, about a real oil explorer with real potential, and no bs twitter posts to ramp it.

slartybartfaster
27/8/2018
22:49
showing how much money it cost all that work by you just to be buzzed off again to easy
manc10
27/8/2018
22:24
So he didn’t, elrico, want the news on this thread...keep it stum!

Why, if elrico knew about it, didn't he put up for all to see?! NHS funded probably, for those in need! They wouldn’t fund opti’s so called, product, so why not?!

rayrac
27/8/2018
22:21
you will lose a few pounds with that pill about 80 pounds a week lol its already on elrics blogg meanwhile back at the ranch lol
manc10
27/8/2018
22:17
No mention of opti’s product...the medical world isn’t interested!

Holy grail’ weight-loss pill beats middle-age spread
The most effective slimming pill yet helps mature adults shed nine pounds on average
By Laura Donnelly, Health Editor, in Munich
A BREAKTHROUGH drug that directly targets middle-age spread could help millions of overweight Britons lose weight.
Slimmers taking the pills lost three times as much weight as those simply trying to diet and exercise, a landmark trial found. The drug also cut the risk of diabetes by a fifth.
Experts hailed the drug, called lorcaserin, as the most effective weight-loss pill yet, suggesting it could help the two in three adults who are currently battling weight problems.
The approach could be the “holy grail” in the battle to combat obesity, they said.
The American research, which tracked 12,000 obese or overweight adults, found that four in 10 of those taking the drug lost a significant amount of weight over the course of a year.
On average, slimmers taking the twice-daily pills lost 9lb – around a dress size for the average woman – while those who stuck to traditional diet plans shed just 3lb.
And more than three years after the trial began, those taking the pills had kept the weight off, the study found.
Scientists said the drug was an “important milestone” after decades of failed attempts to to develop effective diet medication to combat the growing global obesity epidemic.
Until now, drugs that showed early promise have had little success – or been dogged by safety concerns, in particular about potential dangers to the heart. Harvard researchers said their results, presented at the world’s largest cardiac conference, showed for the first time that a drug could cause consistent and sustained weight loss with no such risks.
Scientists said the breakthrough was particularly significant because the drug targets signals in the brain that have been linked to weight gain in middle age.
The drug works by activating the neurons in the brain that control “satiety”; – signalling fullness.
These neurons become less efficient with age, which is believed to be a key cause of middle-age spread.
Experts said the new drug – which is currently licensed in the US, and costs around £220 a month – works by reinvigorating the cells, helping people better control their appetite.
Eisai, the drug maker, said it was now evaluating the findings, ahead of any application for a European licence.
Prof Jason Halford, an obesity expert at the University of Liverpool, said the drug could help millions of Britons if it was given the go-ahead by the NHS.
“We don’t have any appetite suppressants available on the NHS. We have a massive great gap between lifestyle modification and surgery. At the moment you either get support and advice, or you get surgery – there is nothing in-between,” he said.
“This could be widely prescribed if it is approved by Nice (the National Institute of Health and Care Excellence) in the UK,” he said.
The findings, presented at the European Society of Cardiology conference in Munich, and published in the New England Journal of Medicine, yesterday prompted excitement among obesity and cardiac experts.
Tam Fry, of the National Obesity Forum, said it was the “holy grail” of anti-obesity medication.
The only weight-loss drug currently available on the NHS is orlistat – which stops fat being absorbed into the body.
For years, attempts to develop “centrally acting” appetite suppressors – which make people feel they are full more quickly – have been beset with difficulties because until now they have also caused cardiac problems.
The findings suggest the new approach is around twice as effective as orlistat, which can have unpleasant side effects.
While 21 per cent of those taking orlistat lost at least five per cent of their total body weight after one year, the new trial found 37 per cent of dieters lost this much weight after 12 months on lorcaserin.
And those on the new drug also saw the risk of developing diabetes fall by 19 per cent, compared with those given a placebo. Erin Bohula, a cardiovascular medicine and critical care specialist at Harvard’s Brigham and Women’s Hospital and the lead author, said the findings were an “important milestone” after decades of failed attempts to develop a safe drug, while global obesity rates have tripled.
“We have been able to demonstrate for the first time in a rigorous, randomised way that this weight loss drug does what it is intended to do without causing an increase in adverse cardiovascular events in a population at higher risk for heart attacks and strokes,” she said.
While rates of major cardiac events were almost identical in those taking the drug, compared with the control group, those on the pills saw “small but significant” improvements in several factors linked to heart disease – including blood pressure, heart rate and blood sugar levels, the study found.
Prof Jeremy Pearson, associate medical director at the British Heart Foundation, said the findings were “reassuring221; after a “long and generally unhappy” history of attempts at success in the field.

rayrac
27/8/2018
13:07
Raywhack, keep setting them up for manc10, he's killing you. lol
slartybartfaster
27/8/2018
09:08
Guru tipster no life lol
manc10
27/8/2018
09:06
Lacky’s...
rayrac
27/8/2018
09:04
just for dr of science rayrac hxxp://optibiotix.com/product/lpldl/
manc10
27/8/2018
08:53
Over 12 weeks? Not likely! A product that had that control over human health would have to go through thorough phase 1/2/3 trials.

Pull the other one! Lot of wishful dreaming here?

rayrac
26/8/2018
20:11
They already have a cholesterol and BP product!

LPLDL® has been shown in randomised, placebo controlled human intervention studies to deliver tangible health benefits, reducing cardiovascular risk factors and supporting overall heart wellness. These include:
• Lower total cholesterol by up to 36.7%
• Lower LDL cholesterol by up to 13.9%
• Increase HDL cholesterol by up to 6.5%
• Lower systolic blood pressure by 5.1%
• Be completely safe and well tolerated

asterix96
26/8/2018
14:58
elrico just posted a very intriguing find which refers to a 2 in 1 pill for cardio. He makes the point OPTI had developed a worlds first, cholesterol and BP product. The article published in the sun says this was discussed at a munich congress. HLH is German. I'm sure elrico is making the appropriate enquiries.
slartybartfaster
26/8/2018
14:12
Parsons, it's been a calculated effort from Monkeywench to destroy this thread. Then when he started sending threats to Elrico, I think that essentially finished it off. Elrico is extremely well researched on OPTI and has created another thread where others have followed, me included. This thread is dead. Probably makes sense for someone with a Premium account to begin another where they're able to ban other Premium trolls.
polus
26/8/2018
14:12
There's nothing to say because the company hasn't released any deal news for two months. Results this week should generate some interest (one way or the other)
someuwin
26/8/2018
13:56
This site is going from BAD to WORSE, pretty well all of the posts this weekend are about infighting between the bulls and bears of the stock. A waste of every-ones time !!!
parsons4
Chat Pages: Latest  1727  1726  1725  1724  1723  1722  1721  1720  1719  1718  1717  1716  Older

Your Recent History

Delayed Upgrade Clock